The Study
Lupin protein isolate improves insulin sensitivity and steatohepatitis in vivo and modulates the expression of the Fasn, Gys2, and Gsk3b genes
This study gave rats a special protein and saw that their blood sugar and liver got better. But it didn't test this on people, so we can't say it will work for humans. It's like seeing a toy car work on a ramp — it doesn't mean a real car will do the same.
Analysis score
Maximum 90 for a randomized controlled trial.
Where the score came from
Scientists gave a protein from lupin beans to overweight rats that had trouble using sugar, and their bodies got better at it.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 519 / 100
Quality score
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — these changes suggest the protein could help treat obesity-related diabetes and fatty liver disease, though it’s only been tested in rats so far.
- 2The rats' sugar control improved by 27% (AUC dropped from 6,777 to 4,971), blood sugar fell by 33%, fat levels dropped by 34%, and liver damage improved in 3 out of 5 treated rats.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Food Science & Nutrition
Year
2021
Authors
I. C. Soto-Luna, P. García-López, B. Vargas-Guerrero, T. J. Guzmán, J. A. Domínguez-Rosales, C. Gurrola-Díaz
Related Content
Claims (6)
Obese adolescent males who drink soy and lupin protein beverages have higher insulin sensitivity than those who do not.
In rats with insulin resistance caused by diet, lupin protein isolate raises the activity of the Gys2 gene in the liver by 2.8 times compared to rats not given the protein.
In rats with diet-induced metabolic dysfunction, daily consumption of lupin protein isolate for three weeks reduced blood sugar by 33%, lowered triglycerides by 34%, decreased total cholesterol by 37%, and improved insulin sensitivity by 27%.
In rats with insulin resistance caused by diet, lupin protein isolate lowers liver Fasn gene activity by about half compared to untreated rats, which is linked to reduced fat production in the liver.
In rats with fatty liver disease caused by diet, lupin protein isolate lowered liver inflammation and scarring, with three of five treated rats improving from severe to mild disease, while all untreated rats remained severely affected.
In rats with insulin resistance caused by diet, lupin protein isolate increases Gsk3b gene activity in the liver, leading to reduced suppression of glycogen synthase and enhanced insulin signaling.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.